CSIMarket
 


Amphastar Pharmaceuticals Inc   (AMPH)
Other Ticker:  
 
 

AMPH's EPS from Cont. Operations Growth by Quarter and Year

Amphastar Pharmaceuticals Inc 's EPS from Cont. Operations results by quarter and year




AMPH EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.70 0.41 -0.13
III Quarter September 1.01 0.32 0.62 0.08
II Quarter June 0.54 0.35 0.16 0.00
I Quarter March 0.54 0.50 0.11 0.09
FY   2.09 1.87 1.30 0.04



AMPH EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment
Amphastar Pharmaceuticals Inc achieved in the third quarter 2023, above Company average EPS from Cont. Operations surge of 215.63% year on year, to $ 1.01 .

Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher EPS from Cont. Operations growth. While Amphastar Pharmaceuticals Inc ' s EPS from Cont. Operations doubling of 215.63% ranks overall at the positon no. 133 in the third quarter 2023.




AMPH EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 70.73 % - -
III Quarter September 215.63 % -48.39 % 675 % 166.67 %
II Quarter June 54.29 % 118.75 % - -
I Quarter March 8 % 354.55 % 22.22 % 350 %
FY   - 43.85 % 3150 % -96.15 %

Financial Statements
Amphastar Pharmaceuticals Inc 's third quarter 2023 EPS from Cont. Operations $ 1.01 AMPH's Income Statement
Amphastar Pharmaceuticals Inc 's third quarter 2022 EPS from Cont. Operations $ 0.32 Quarterly AMPH's Income Statement
New: More AMPH's historic EPS from Cont. Operations Growth >>


AMPH EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 118.75 % -33.87 % -
III Quarter September 87.04 % -8.57 % 287.5 % -
II Quarter June 0 % -30 % 45.45 % -
I Quarter March -22.86 % 21.95 % - -
FY (Year on Year)   - 43.85 % 3150 % -96.15 %




EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #7
Overall #133

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
675 % 112 % -100 %
(Sep 30 2021)   (Jun 30 2020)
EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #7
Overall #133
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
675 % 112 % -100 %
(Sep 30 2021)   (Jun 30 2020)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Amphastar Pharmaceuticals Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
4950 % 309.38 % -100 %
(Jun 30 2019)  


AMPH's III. Quarter Q/Q EPS from Cont. Operations Comment
Amphastar Pharmaceuticals Inc achieved in the III. Quarter 2023 below company average EPS from Cont. Operations jump of 87.04% quarter on quarter, to $ 1.01 .

III. Quarter 2023 Amphastar Pharmaceuticals Inc 's performance seem to be a mixed bag, even if beneath the ordinary, yet it shows a quite acceleration compare to the -8.57% in the III. Quarter a year ago

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amphastar Pharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 140.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #9
Overall #140
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #9
Overall #140
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
4950 % 309.38 % -100 %
(Jun 30 2019)  


AMPH's III. Quarter Q/Q EPS from Cont. Operations Comment
Amphastar Pharmaceuticals Inc achieved in the III. Quarter 2023 below company average EPS from Cont. Operations jump of 87.04% quarter on quarter, to $ 1.01 .

III. Quarter 2023 Amphastar Pharmaceuticals Inc 's results were a mixed bag, even if lower than the average, yet it demonstrates real acceleration relative to the -8.57% in the III. Quarter 2022.

Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amphastar Pharmaceuticals Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 140.


Amphastar Pharmaceuticals Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ 2.79 $ 2.10 $ 1.91 $ 1.87 $ 1.58
Y / Y EPS from Cont. Operations Growth (TTM) 76.37 % 11.63 % 12.94 % 43.67 % 108.87 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 124 # 25 # 35 # 37 # 186
Seqeuential EPS from Cont. Operations Change (TTM) 32.82 % 9.94 % 2.14 % 18.26 % -15.93 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 902 # 644 # 452 # 244 # 1491




Cumulative EPS from Cont. Operations growth Comment
Although Amphastar Pharmaceuticals Inc 's Annual EPS from Cont. Operations growth year on year were below company's average 439.9% , EPS from Cont. Operations announced in the Sep 30 2023 period, show improvement in EPS from Cont. Operations trend, to cumulative trailing twelve month growth of 76.37% year on year, from 11.63% in Jun 30 2023.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 25 to 124.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
2061.73 %
439.9 %
11.63 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 7
Overall # 124

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
2061.73 %
439.9 %
11.63 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 55
S&P 500 # 902
Cumulative EPS from Cont. Operations growth Comment
Although Amphastar Pharmaceuticals Inc 's Annual EPS from Cont. Operations growth year on year were below company's average 439.9% , EPS from Cont. Operations announced in the Sep 30 2023 period, show improvement in EPS from Cont. Operations trend, to cumulative trailing twelve month growth of 76.37% year on year, from 11.63% in Jun 30 2023.

Among companies within the Healthcare sector 6 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While EPS from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 25 to 124.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
2061.73 %
439.9 %
11.63 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 7
Overall # 124

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
2061.73 %
439.9 %
11.63 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 11
Sector # 55
S&P 500 # 902




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
AMPH's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for AMPH's Competitors
EPS from Cont. Operations Growth for Amphastar Pharmaceuticals Inc 's Suppliers
EPS from Cont. Operations Growth for AMPH's Customers

You may also want to know
AMPH's Annual Growth Rates AMPH's Profitability Ratios AMPH's Asset Turnover Ratio AMPH's Dividend Growth
AMPH's Roe AMPH's Valuation Ratios AMPH's Financial Strength Ratios AMPH's Dividend Payout Ratio
AMPH's Roa AMPH's Inventory Turnover Ratio AMPH's Growth Rates AMPH's Dividend Comparisons



Companies with similar EPS from Cont. Operations jump for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2023
Amphastar Pharmaceuticals Inc 215.63%$ 215.625 
Alpha Pro Tech Ltd 200.00%$ 200.000 
Conduit Pharmaceuticals Inc 200.00%$ 200.000 
Boston Scientific Corporation183.33%$ 183.333 
Viemed Healthcare Inc 166.67%$ 166.667 
Davita Inc 132.76%$ 132.759 
Cadre Holdings Inc 123.08%$ 123.077 
Lantheus Holdings Inc 116.85%$ 116.854 
Orasure Technologies Inc114.29%$ 114.286 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com